Outcome-oriented and patient-experienced impact of the COVID-19 pandemic on healthcare accessibility and use of rheumatological care in the Netherlands

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 05160482310002

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2023
    2025
  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)
  • Principal Investigator

    dr. D Lopes barreto PhD
  • Research Location

    N/A
  • Lead Research Institution

    Maasstad Ziekenhuis
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Other

  • Occupations of Interest

    Unspecified

Abstract

During the COVID-19 pandemic, there was reduced accessibility to outpatient care for rheumatoid arthritis (RA) patients due to care downscaling, but also because some patients chose to avoid the overburdened healthcare system. As a result, rheumatological care has been delivered in a different way, including the accelerated adaptation of remote care. Goal The aim of this quantitative and qualitative research is to use outcome information to substantiate the knowledge gap as to whether the (drug) treatment for RA patients was optimal during the COVID-19 pandemic by reducing the number of physical consultations. Method By using real-world data, we gain insight into the further development of appropriate care during the accelerated implementation of care substitution. This knowledge will be used to optimize the care process and as a starting point for the outcome-oriented delivery of rheumatological care from a social and patient perspective.